Agios Stock Down Year: Why It Fell 16% and What Next
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
Learn various ways to save money while studying, helping you build your financial skills and enjoy a more manageable budget during college.
27,538 articlesBiotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
Mativ's 2025 earnings cycle reveals a company navigating macro headwinds with disciplined execution. This article bre...
Hims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
HUD opens a formal review of HECM reforms as proprietary reverse mortgage options expand. Industry leaders weigh in o...
AMH reports solid 2025 results as it navigates an overbuilt rental market, with revenue gains driven by disciplined a...
Sitting on a 1.1% S&P yield can feel underwhelming. These three dividend stocks double right now offer stronger incom...
Lemonade posted first positive GAAP free cash flow in the latest quarter, a milestone that reshapes the insurtech nar...
The spring 2026 housing market arrives with affordability takes center stage. Higher mortgage costs and tight invento...
Lighter’s upgraded liquidity framework held firm during a $50 million ARC perpetual squeeze, enforcing a $75,000 cap ...
OpenAI is renegotiating its Pentagon deal to block domestic surveillance, with new safeguards and agency restrictions...
Target has stunned the market with surprising margins and a rebound in sales. This article digs into whether the rall...
Policy shifts around AI chips could change how Nvidia and AMD ship GPUs worldwide. This article breaks down the risks...